We are delighted to introduce Henning Thiel, International Business Development Manager, to the Colonis team as we continue to strengthen our capabilities and accelerate our international growth ambitions.
Henning brings over 20 years of experience in global business development, licensing, and international market expansion. He recently served as an Associate Director of Business Development, where he led international licensing initiatives and developed EU-wide internationalisation strategies. Henning has also held senior business development positions with other international pharma companies, where he drove cross-functional launch coordination, conducted product evaluations, and forged key partnerships across Europe and Asia.
Based in Germany, Henning will focus on advancing our in-licensing strategy across the UK and EU, supporting our wider international strategy.
Henning’s extensive experience and strategic insight will be invaluable as we continue to grow our international presence, ensuring that Colonis can continue to bring value added medicines to markets globally.
We warmly welcome Henning to the Colonis team and look forward to the contribution he will make to our international growth strategy.
GB-CPL-0-341
December 2025